Urinary lipoarabinomannan (LAM) detection is a promising approach for rapid diagnosis of active tuberculosis
(TB). In microbiologically confirmed TB patients, quantitative LAM detection results increased progressively
with bacillary burden and immunosuppression. Patients with disseminated TB and/or advanced HIV
are target populations for whom urine LAM detection may be particularly useful.